Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.

Yukihide Kanemitsu,Yasuhiro Shimizu,Junki Mizusawa,Yoshitaka Inaba,Tetsuya Hamaguchi,Dai Shida,Masayuki Ohue,Koji Komori,Akio Shiomi,Manabu Shiozawa,Jun Watanabe,Takeshi Suto,Yusuke Kinugasa,Yasumasa Takii,Hiroyuki Bando,Takaya Kobatake,Masafumi Inomata,Yasuhiro Shimada,Hiroshi Katayama,Haruhiko Fukuda

Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.

2021

PURPOSEAdjuvant chemotherapy after hepatectomy is controversial in liver-only metastatic colorectal cancer (CRC). We conducted a randomized controlled trial to examine if adjuvant modified infusion...

Keywords:

Randomized controlled trial
Hepatectomy
Oncology
Colorectal cancer
Adjuvant
Internal medicine
Chemotherapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations